DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
968
MDX-CD4
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MDX-CD4
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RO6958688
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
RO6958688
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SAR-1349
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
SAR-1349
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELGEMTUMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Squamous Cell; Esophageal Neoplasms
Receptor tyrosine-protein kinase erbB-3 inhibitor
ELGEMTUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
5F1CN52GFM
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REVDOFILIMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Head and Neck Neoplasms; Neoplasms
Unknown
REVDOFILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
2Y83Y2ORD3
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GALEGENIMAB
1
Antibody
Investigational
Unknown
Unknown
Macular Degeneration
Unknown
GALEGENIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
M170
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
M170
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PATRITUMAB DERUXTECAN
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung
DNA topoisomerase I inhibitor
PATRITUMAB DERUXTECAN
×
Maximum Phase:
1
First Approval:
None
UNII:
3XPI7EG4W8
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NIVATROTAMAB
1
Antibody
Investigational
Unknown
Unknown
Small Cell Lung Carcinoma
Unknown
NIVATROTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ENAPOTAMAB VEDOTIN
1
Antibody
Investigational
Unknown
Unknown
Unknown
Tubulin inhibitor
ENAPOTAMAB VEDOTIN
×
Maximum Phase:
1
First Approval:
None
UNII:
43HH4XYH2N
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COFETUZUMAB PELIDOTIN
1
Antibody
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
COFETUZUMAB PELIDOTIN
×
Maximum Phase:
1
First Approval:
None
UNII:
249EAP69MT
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HEFI-1
1
Antibody
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Tumor necrosis factor receptor superfamily member 8 binding agent
HEFI-1
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEDI-3617
1
Antibody
Investigational
Unknown
Unknown
Melanoma; Neoplasms
Angiopoietin-2 inhibitor
MEDI-3617
×
Maximum Phase:
1
First Approval:
None
UNII:
6RH6DL8R4L
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LETOLIZUMAB
1
Antibody
Investigational
Unknown
Unknown
Graft vs Host Disease
Unknown
LETOLIZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
449MIE2SD6
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SGN-CD33A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
SGN-CD33A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SUVIZUMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
SUVIZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
4AJ2TI6DPI
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ABAGOVOMAB
1
Antibody
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Peritoneal Neoplasms; Ovarian Neoplasms
Mucin-16 other
ABAGOVOMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
3YK0326U7X
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1D09C3
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
1D09C3
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIIB-022
1
Antibody
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Neoplasms
Insulin-like growth factor I receptor inhibitor
BIIB-022
×
Maximum Phase:
1
First Approval:
None
UNII:
Y60655Y65T
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MOC31-PE
1
Antibody
Investigational
Unknown
Unknown
Carcinoma
Epithelial cell adhesion molecule binding agent
MOC31-PE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-03732010
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Cadherin-3 inhibitor
PF-03732010
×
Maximum Phase:
1
First Approval:
None
UNII:
LPW79O1J5Z
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYT-500 177LU
1
Antibody
Investigational
Unknown
Unknown
Prostatic Neoplasms
Glutamate carboxypeptidase II binding agent
CYT-500 177LU
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UBAMATAMAB
1
Antibody
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Ovarian Neoplasms
Unknown
UBAMATAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CEVOSTAMAB
1
Antibody
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
CEVOSTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MLN-2704
1
Antibody
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Glutamate carboxypeptidase II binding agent
MLN-2704
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HCBE-11
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Tumor necrosis factor receptor superfamily member 3 agonist
HCBE-11
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
14G2A
1
Antibody
Investigational
Unknown
Unknown
Epstein-Barr Virus Infections; Neuroblastoma
Disialoganglioside GD2 inhibitor
14G2A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EZABENLIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
EZABENLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
E2.3
1
Antibody
Investigational
Unknown
Unknown
Leukemia; Multiple Myeloma; Myelodysplastic Syndromes; Myeloproliferative Disorders
Transferrin receptor inhibitor
E2.3
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
JNJ-61186372
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
JNJ-61186372
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MIK-BETA-1
1
Antibody
Investigational
Unknown
Unknown
Leukemia
Interleukin-2 receptor beta chain inhibitor
MIK-BETA-1
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FP-1305
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
FP-1305
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LUMILIXIMAB
1
Antibody
Investigational
Unknown
Unknown
Leukemia; Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell
Immunoglobulin epsilon Fc receptor antagonist
LUMILIXIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
8Z13S29R5A
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TB-403
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Placenta growth factor inhibitor
TB-403
×
Maximum Phase:
1
First Approval:
None
UNII:
46MVG4H2LF
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SC-1
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
SC-1
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
6
7
8
9
10
11
12
…
27
28
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA